The short answer
Goldenseal has the potential to interfere with warfarin metabolism, but the inspected evidence does not quantify its effect on INR or warfarin concentrations in patients. Warfarin labeling names goldenseal as a potential metabolic interaction. Laboratory enzyme findings explain the concern without establishing a predictable clinical effect.
What this answer covers
Oral Hydrastis canadensis preparations with oral warfarin. Isolated berberine or hydrastine, other plants containing these alkaloids and different extract compositions remain distinct exposures.
- Supplement or preparation
- Goldenseal
- Medication ingredient
- warfarin
What does the evidence show?
A primary laboratory study tested goldenseal alkaloids in human liver microsomes and recombinant enzymes. Hydrastine inhibited CYP2C9, while other alkaloids affected additional enzymes. These pathways are relevant to drug metabolism, but the experiments used probe substrates and did not administer goldenseal with warfarin to patients. The inspected warfarin label lists goldenseal among botanicals capable of CYP450 interactions. These sources support biological plausibility and a monitoring precaution, not a measured patient-level increase or decrease in warfarin exposure.
Which forms and conditions matter?
Whole goldenseal extract contains several constituents with different enzyme effects. A result for an isolated constituent cannot be treated as the measured action of every capsule. The same caution applies to substituting a berberine supplement for goldenseal in the evidence record. Botanical identity and preparation details need to be checked before interpreting a possible interaction.
What should I discuss with my care team?
Have the anticoagulation clinician or pharmacist assess the product before starting or stopping it. If co-use occurs, the clinician can decide on additional INR monitoring and account for other causes of changed warfarin response. Taking goldenseal and warfarin at different clock times is not a validated solution to a possible enzyme interaction.
How certain is the answer?
Targeted searches did not yield an inspected direct human goldenseal-warfarin pharmacokinetic trial. This does not establish safety or exclude an interaction. The article avoids converting enzyme inhibition in a laboratory into a definite clinical blood-level prediction, and it does not invent a magnitude, onset or dose adjustment.
Evidence and practical considerations
Absorption & effectiveness
Goldenseal has the potential to interfere with warfarin metabolism, but the inspected evidence does not quantify its effect on INR or warfarin concentrations in patients. Warfarin labeling names goldenseal as a potential metabolic interaction. Laboratory enzyme findings explain the concern without establishing a predictable clinical effect.
- Exact scope
- Oral Hydrastis canadensis preparations with oral warfarin. Isolated berberine or hydrastine, other plants containing these alkaloids and different extract compositions remain distinct exposures. with Oral warfarin, including warfarin sodium tablets with the warfarin active moiety.
- Medication form and route
- oral warfarin
- Timing or duration
- Study-specific durations are described in each source exposure; no universally safe exposure duration has been established.
What remains uncertain
- Targeted searches did not yield an inspected direct human goldenseal-warfarin pharmacokinetic trial. This does not establish safety or exclude an interaction. The article avoids converting enzyme inhibition in a laboratory into a definite clinical blood-level prediction, and it does not invent a magnitude, onset or dose adjustment.
Factors that may matter: Exact supplement preparation and other ingredients; Starting, stopping or changing supplement intake; Baseline anticoagulation control and clinician-supervised monitoring.
Read the supporting source summaries
Source 1: current U.S. regulatory prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed oral warfarin sodium tablets.
The label advises closer INR monitoring when botanicals are started or stopped, identifies variable botanical composition and lists selected potential interactions. Vitamin K intake should remain consistent.
How this applies: Oral warfarin sodium has warfarin as its active moiety. Label-level botanical and vitamin K monitoring advice applies; it is not proof of this exact supplement effect. Oral Hydrastis canadensis preparations with oral warfarin. Isolated berberine or hydrastine, other plants containing these alkaloids and different extract compositions remain distinct exposures.
Regulatory precautions do not quantify the incidence for every exact preparation or prove an interaction for an unlisted ingredient. Warfarin sodium is bridged to the warfarin active moiety only for the oral product.
Source 2: laboratory metabolism study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Human liver microsomes and recombinant enzymes, not patients receiving warfarin.
Time-dependent inhibition of drug-metabolizing enzymes, including CYP2C9 by hydrastine, was demonstrated.
How this applies: Goldenseal alkaloid enzyme experiments are indirect for Hydrastis canadensis with warfarin. No direct clinical warfarin absorption or INR conclusion follows. Exact package scope: Oral Hydrastis canadensis preparations with oral warfarin. Isolated berberine or hydrastine, other plants containing these alkaloids and different extract compositions remain distinct exposures.
Warfarin was not the clinical test drug. Enzyme findings require exposure modeling and cannot establish patient blood levels, direction of INR change or risk magnitude for goldenseal products.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Original evidence and contradictory findings assessed for this exact pair. Article drafted and existing statements adjudicated. Clinical sign-off has not been recorded. | |
| Research summary published |
Article revision: 983ab15f3052c306
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.